drugset
drugset / Trial / NCT03390972

Dexmedetomidine and Swallowing Function

NCT03390972 ↗

Phase 4 Unknown 20 enrolled Region Örebro County
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of the study is to evaluate the impact of dexmedetomidine on swallowing function in healthy volunteers using combined pressure and impedance recordings. Furthermore, two different concentrations of dexmedetomidine will be studied to find out whether any posible impact of dexmedetomidine on swallowing function is dose-dependent.

Timeline

Start
2018-01-22
Primary completion
2018-04-11
Completion
2018-04-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.6 ng/ml Intravenous
Subject Dexmedetomidine Other / unclassified 1.2 ng/ml Intravenous

Indications

No indication recorded.